News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen Class of 2024
Insights
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Jobs
Career Advice
Companies
Hotbeds
More
Employer Resources
Best Places to Work
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen Class of 2024
Insights
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Jobs
Career Advice
Companies
Hotbeds
More
Employer Resources
Best Places to Work
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
677,353 Results
Type
Article (38716)
Company Profile (246)
Press Release (638391)
Section
Business (203347)
Career Advice (1974)
Deals (35346)
Drug Delivery (77)
Drug Development (80537)
Employer Resources (167)
FDA (15977)
Job Trends (14773)
News (343377)
Policy (32401)
Tag
Academia (2528)
Africa (710)
Alliances (48922)
Alzheimer's disease (1132)
Approvals (15923)
Arizona (169)
Artificial intelligence (64)
Asia (36698)
Australia (5967)
Bankruptcy (350)
Best Places to Work (11209)
Biosimilars (60)
Biotechnology (170)
C2C Services and Suppliers (78803)
California (1520)
Canada (829)
Cancer (319)
Career advice (1644)
Cell therapy (96)
China (109)
Clinical research (62892)
Collaboration (105)
Colorado (63)
Connecticut (59)
COVID-19 (2471)
Cystic fibrosis (71)
Data (124)
Diabetes (64)
Diagnostics (5940)
Drug pricing (59)
Earnings (83608)
Employer resources (140)
Europe (78381)
Events (107309)
Executive appointments (86)
FDA (16141)
Florida (207)
Funding (91)
Gene therapy (73)
GLP-1 (497)
Government (4282)
Healthcare (18569)
Hotbed/Location (480973)
Idaho (56)
Illinois (230)
Indiana (133)
Infectious disease (2495)
Inflammatory bowel disease (86)
Interviews (305)
IPO (16163)
Job creations (3619)
Job search strategy (1411)
Kansas (93)
Layoffs (388)
Legal (7827)
Lung cancer (69)
Manufacturing (71)
Maryland (336)
Massachusetts (1272)
Medical device (13013)
Medtech (13016)
Mergers & acquisitions (18987)
Metabolic disorders (213)
Michigan (114)
Minnesota (201)
Neuroscience (1241)
New Jersey (468)
New York (476)
NextGen Class of 2024 (6477)
Non-profit (4452)
North Carolina (554)
Northern California (693)
Obesity (132)
Ohio (96)
Opinion (167)
Patents (55)
Pennsylvania (511)
People (55683)
Pharmaceutical (59)
Phase I (19479)
Phase II (27702)
Phase III (20706)
Pipeline (91)
Postmarket research (2545)
Preclinical (8291)
Press Release (64)
Rare diseases (111)
Real estate (5878)
Recruiting (63)
Regulatory (21127)
Research institute (2300)
Resumes & cover letters (345)
South America (1084)
Southern California (624)
Startups (3554)
Texas (179)
United States (7260)
Vaccines (443)
Washington State (232)
Weight loss (116)
Date
Last 7 days (461)
Last 30 days (2176)
Last 365 days (37408)
2024 (24437)
2023 (40076)
2022 (51175)
2021 (55713)
2020 (54087)
2019 (46543)
2018 (35025)
2017 (32115)
2016 (31481)
2015 (37553)
2014 (31318)
2013 (26346)
2012 (28570)
2011 (29264)
2010 (27328)
677,353 Results for "veru inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
BioMidwest
Veru to Present at the 2024 Jefferies Global Healthcare Conference
Veru Inc. announced that Mitchell Steiner, M.D., Chairman, President and Chief Executive Officer of Veru, will present an update of Veru’s Phase 2b clinical program of enobosarm to augment fat loss and to avoid muscle loss when combined with GLP-1 drugs for weight loss at the Jefferies Global Healthcare Conference on Wednesday, June 5, 2024 at 11:00 am – 11:25 am ET.
May 22, 2024
·
10 min read
BioMidwest
Veru Adjourns 2024 Annual Meeting of Shareholders to June 27, 2024
Veru Inc. announced that its Annual Meeting of Shareholders scheduled for today was convened and adjourned without any business being conducted due to lack of a required quorum.
June 18, 2024
·
7 min read
BioMidwest
Veru to Present at the American Diabetes Association’s 84th Scientific Sessions
Veru Inc. announced that the Company will present two presentations at the American Diabetes Association’s 84th Scientific Sessions, taking place June 21-24, 2024, in Orlando, Florida.
June 10, 2024
·
10 min read
Veru Announces Safety and Body Composition Data from Two Late-Breaker Presentations at the American Diabetes Association’s 84th Scientific Sessions
Veru Inc. (NASDAQ: VERU) today announced data from two late-breaker presentations at the American Diabetes Association’s 84th Scientific Sessions, which took place on June 21-24, 2024, in Orlando, Florida.
June 24, 2024
·
11 min read
Veru to Present at the GLP-1 Based Therapeutics Summit
Veru Inc. today announced that the Company has been invited to give a presentation at the GLP-1 Based Therapeutics Summit, taking place May 15-16, 2024, in Philadelphia, PA.
May 2, 2024
·
7 min read
BioMidwest
Veru Reminds Shareholders to Vote in Advance of Tomorrow’s Deadline for 2024 Annual Meeting of Shareholders
Veru Inc., a late clinical stage biopharmaceutical company focused on developing innovative medicines for preserving muscle for high quality weight loss, oncology, and viral induced acute respiratory distress syndrome, would like to remind shareholders to vote in connection with the Company’s upcoming annual meeting of shareholders, to be held on Tuesday, June 18, 2024, at 9:00 AM ET.
June 17, 2024
·
6 min read
Veru to Present at the American Association of Clinical Endocrinology (AACE) 2024 Annual Meeting on May 9-11
Veru Inc. (NASDAQ: VERU) today announced that the Company will present two late-breaking abstract presentations at the American Association of Clinical Endocrinology (AACE) 2024 Annual Meeting, taking place May 9-11, 2024 in New Orleans, LA.
April 25, 2024
·
7 min read
Business
Veru Reports Fiscal 2024 Second Quarter Financial Results and Progress of its Enobosarm High Quality Weight Loss Clinical Program
Veru Inc. announced financial results for its fiscal 2024 second quarter and provided a business update.
May 8, 2024
·
15 min read
BioMidwest
Veru Reschedules Annual Meeting of Shareholders - March 22, 2024
Veru Inc. announced that it is rescheduling its 2024 Annual Meeting of Shareholders originally scheduled to be held on March 26, 2024.
March 22, 2024
·
7 min read
Business
Veru to Report Fiscal 2024 Second Quarter Financial Results on May 8, 2024
Veru Inc. today announced it will host a conference call and audio webcast on Wednesday, May 8, 2024, at 8:00 a.m. ET to discuss its fiscal 2024 second quarter financial results and to provide a business update.
May 1, 2024
·
4 min read
1 of 67,736
Next